265 related articles for article (PubMed ID: 29311338)
1. Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.
Conforti P; Besusso D; Bocchi VD; Faedo A; Cesana E; Rossetti G; Ranzani V; Svendsen CN; Thompson LM; Toselli M; Biella G; Pagani M; Cattaneo E
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E762-E771. PubMed ID: 29311338
[TBL] [Abstract][Full Text] [Related]
2. Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.
Ring KL; An MC; Zhang N; O'Brien RN; Ramos EM; Gao F; Atwood R; Bailus BJ; Melov S; Mooney SD; Coppola G; Ellerby LM
Stem Cell Reports; 2015 Dec; 5(6):1023-1038. PubMed ID: 26651603
[TBL] [Abstract][Full Text] [Related]
3. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.
Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW
Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal instability during neurogenesis in Huntington's disease.
Ruzo A; Croft GF; Metzger JJ; Galgoczi S; Gerber LJ; Pellegrini C; Wang H; Fenner M; Tse S; Marks A; Nchako C; Brivanlou AH
Development; 2018 Jan; 145(2):. PubMed ID: 29378824
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
Castiglioni V; Onorati M; Rochon C; Cattaneo E
Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
7. Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.
Smail S; Bahga D; McDole B; Guthrie K
Chem Senses; 2016 Mar; 41(3):221-32. PubMed ID: 26783111
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model.
Baronchelli S; La Spada A; Ntai A; Barbieri A; Conforti P; Jotti GS; Redaelli S; Bentivegna A; De Blasio P; Biunno I
Mol Cell Neurosci; 2017 Jul; 82():46-57. PubMed ID: 28476540
[TBL] [Abstract][Full Text] [Related]
9. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
10. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
Xu X; Tay Y; Sim B; Yoon SI; Huang Y; Ooi J; Utami KH; Ziaei A; Ng B; Radulescu C; Low D; Ng AYJ; Loh M; Venkatesh B; Ginhoux F; Augustine GJ; Pouladi MA
Stem Cell Reports; 2017 Mar; 8(3):619-633. PubMed ID: 28238795
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington's Disease.
Mathkar PP; Suresh D; Dunn J; Tom CM; Mattis VB
J Huntingtons Dis; 2019; 8(3):257-269. PubMed ID: 31381521
[TBL] [Abstract][Full Text] [Related]
12. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
[TBL] [Abstract][Full Text] [Related]
13. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
14. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics.
Akimov SS; Jiang M; Kedaigle AJ; Arbez N; Marque LO; Eddings CR; Ranum PT; Whelan E; Tang A; Wang R; DeVine LR; Talbot CC; Cole RN; Ratovitski T; Davidson BL; Fraenkel E; Ross CA
Hum Mol Genet; 2021 Nov; 30(24):2469-2487. PubMed ID: 34296279
[TBL] [Abstract][Full Text] [Related]
15. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
[TBL] [Abstract][Full Text] [Related]
16. Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype.
Mazurová Y; Gunčová I; Látr I; Rudolf E
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):486-99. PubMed ID: 21495959
[TBL] [Abstract][Full Text] [Related]
17. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
18. ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation.
Zimmermann T; Remmers F; Lutz B; Leschik J
Stem Cell Reports; 2016 Oct; 7(4):693-706. PubMed ID: 27693427
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.
Zhang N; An MC; Montoro D; Ellerby LM
PLoS Curr; 2010 Oct; 2():RRN1193. PubMed ID: 21037797
[TBL] [Abstract][Full Text] [Related]
20. Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy.
Csobonyeiova M; Polak S; Danisovic L
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32213859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]